Fig. 1: Systemic Anti-Cancer Treatment (SACT) Delivery in Scotland during the COVID-19 Pandemic.

a Weekly number of patient attendances for systemic anticancer treatment (SACT) in NHS Scotland between the week beginning (wb) 20 January 2020 and the wb 20 July 2020. b Weekly SACT treatment episodes in NHS Scotland by route of administration, intravenous (IV), subcutaneous (SC) or oral. c Percent change in weekly patient attendances for SACT by regional cancer networks. Percentage change calculated relative to a baseline value determined by the average number of national patient attendances in the 6-week prior to the week beginning 2 March 2020. South of Scotland Cancer Network (SCAN), West of Scotland Cancer Network (WoSCAN) and North of Scotland Cancer Alliance (NCA). d Percent change in monthly SACT patient attendance for April 2019 versus April 2020, and June 2019 versus June 2020, by regional cancer networks and in NHS Scotland. e Percent change in weekly SACT treatment episodes by tumour type. Percentage change calculated relative to a baseline value determined by the average number of NHS Scotland treatment episodes in the 8 weeks prior to the week beginning 16 March 2020.